Notice for bioequivalence testing of combination products to be made public in November

The Notice designed to redefine the bioequivalence testing of combined preparations is likely to be delayed due to screening of the Office of Prime Minister and final confirmation of the commissioner of the Korea Food and Drug Administration.

The drug agency said the mandatory bioequivalence system for combination drugs will be implemented in October at the latest.

Sources say this is the...